Pregnancy mineral study aims to unlock secrets of healthy fetal development
NCT ID NCT03598361
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether levels of key minerals like iron, calcium, and zinc in pregnant women are linked to how their babies grow. Researchers will measure these minerals in blood, hair, and amniotic fluid during each trimester. The goal is to create better nutrition advice for pregnant women. About 550 women in early pregnancy will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 550 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2018
- Expected to finish
-
Nov 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
A group of approximately 300 women is planned to be included in the study in the first trimester of pregnancy (up to 14 weeks of pregnancy).
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Diagnosed intrauterine pregnancy until week 14. 2. Single pregnancy without congenital malformations in ultrasound examination. 3. Lack of exponents threatening miscarriage (bleeding, lower abdominal pain, chorionic hematoma). 4. Lack of use of drugs affecting the mineral metabolism of the body. 5. Signing consent to participate in the study. Exclusion Criteria: 1. Ectopic or heterotopic pregnancy. 2. Twin pregnancy (or other multiple pregnancy). 3. Obstetric load in the direction of numerous miscarriages, premature births under 34 weeks, pregnancy, fetal growth disorders (hypotrophy, macrosomia). 4. Congenital and /or genetic defects found in current pregnancy or in the patient. 5. Supply of drugs affecting the mineral metabolism of the body.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pregnancy; disorder, blood are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Poznan University of Life Sciences
RECRUITINGPoznan, 60-624, Poland